Fingerprint
Dive into the research topics of 'PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants
Taru A. Muranen*, Anna Morra, Sofia Khan, Daniel R. Barnes, Manjeet K. Bolla, Joe Dennis, Renske Keeman, Goska Leslie, Michael T. Parsons, Qin Wang, Thomas U. Ahearn, Kristiina Aittomäki, Irene L. Andrulis, Banu K. Arun, Sabine Behrens, Katarzyna Bialkowska, Stig E. Bojesen, Nicola J. Camp, Jenny Chang-Claude, Kamila Czene
*Corresponding author for this work
- Helsinki University Hospital
- University of Helsinki
- The Netherlands Cancer Institute
- University of Cambridge
- QIMR Berghofer Medical Research Institute
- National Cancer Institute
- Mount Sinai Hospital
- University of Toronto
- University of Texas MD Anderson Cancer Center
- German Cancer Research Center
- Pomeranian Medical University
- Copenhagen University Hospital
- University of Copenhagen
- The University of Utah
- University Medical Center Hamburg-Eppendorf
- Karolinska Institute
- Leiden University
- Hospital of the University of Pennsylvania
- Leipzig University
- Department of Genetic Medicine, Manchester University NHS Foundation Trust, Manchester, United Kingdom.
- University of Manchester
- Health Reseaarch Institute of Santiago de Compostela
- Rigshospitalet
- Paris-Sud University
- University Hospital Cologne
- St George's University Hospitals NHS Foundation Trust
- Erasmus University Medical Center Rotterdam
- Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
- Eberhard Karls University of Tübingen
- Guy's and St Thomas' NHS Foundation Trust
- Peter MacCallum Cancer Centre
- Oslo University Hospital
- University of Oslo
- Walter and Eliza Hall Institute of Medical Research
- University of Melbourne
- University of Eastern Finland
- Kuopio University Hospital
- Stockholm South General Hospital
- City of Hope National Medical Center
- University Hospital of South Manchester NHS Foundation Trust
- FIRC Institute for Molecular Oncology Foundation
- CIBERONC
Research output: Contribution to journal › Journal article › Research › peer-review
29
Downloads
(Pure)